Percutaneous Transvenous Transplantation of Autologous Myoblasts in the Treatment of Postinfarction Heart Failure - POZNAN

Description:

The goal of the phase I POZNAN trial was to evaluate safety and feasibility of autologous skeletal myoblast (ASM) transplantation performed with percutaneous transcoronary vein (PTCV) approach in patients with post-myocardial infarction (MI) heart failure.